News
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council, highlights upcoming discussions on ...
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...
Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.
12d
Irish Examiner on MSN'Give it a go': Former patients share their experiences of cancer screeningA diverse network of volunteer representatives who have undergone screening offers the HSE valuable insights into the patient ...
A MOTHER has revealed that she lost over seven stone after using Ozempic for 12 months. Hannah, who is from the United States ...
Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...
Axi-cel, tisa-cel, and brexu-cel were found comparable to other cellular therapy experiences for patients with B-cell ...
One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...
The Northeast Ohio nonprofit "The Superhero Project," founded by Lisa Kollins, creates personalized superhero posters for children facing medical challenges.
Eisai Inc. announced today that the company will present the latest findings from its robust neurology portfolio, including data on real-world experience and continued maintenance dosing with our dual ...
Below is the first round for my mock. You can find this mock, plus a full second round and scouting reports for every single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results